Yahoo Finance • 5 days ago

Alvotech SA (NASDAQ:ALVO) Surpasses Q2 2025 Estimates with Strong Revenue and EPS Growth

ALVOTECH SA (NASDAQ:ALVO [https://www.chartmill.com/stock/quote/ALVO]) REPORTS STRONG Q2 2025 EARNINGS, BEATS REVENUE AND EPS ESTIMATES Alvotech SA, a global biotech company specializing in biosimilar medicines, reported its second-quarte... Full story

Yahoo Finance • 5 days ago

Curious about the stocks that are showing activity after the closing bell on Wednesday?

As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER... Full story

Yahoo Finance • 5 days ago

Alvotech birtir uppgjör fyrir fyrstu sex mánuði ársins og kynnir nýjustu áfanga í rekstri félagsins

Yfir 200% aukning á tekjum af sölu lyfja á fyrri helmingi ársins miðað við sama tíma í fyrraAnnar ársfjórðungur sá besti í sögu félagsins hvað varðar handbært fé frá rekstri Nýir samningar um markaðsetningu endurspegla virði lyfja á fyrri... Full story

Yahoo Finance • 5 days ago

S&P Futures Gain as Fed Rate-Cut Bets Firm

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains as growing expectations for Federal Reserve interest rate cuts fueled risk-on sentime... Full story

Yahoo Finance • 12 days ago

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

REYKJAVIK, ICELAND (August 6, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results f... Full story

Yahoo Finance • 12 days ago

Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. kl. 12 á hádegi

REYKJAVÍK (6. ágúst 2025) Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrri helming ársins 2025 eftir lokun markaða í Bandaríkjunum, miðvikudaginn 13. ágúst nk. Fundur til kynningar á uppgjörinu verður sendur út í b... Full story

Yahoo Finance • 12 days ago

Inbjudan til Alvotech presentation av bokslutskommunikén och rapporten för första halvåret 2025

REYKJAVIK, ISLAND (6 AUGUSTI, 2025) – Alvotech (NASDAQ:ALVO SDB), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära läkemedel för patienter över hela världen, publicerar bokslutskommun... Full story

Yahoo Finance • 21 days ago

Alvotech files automatic mixed securities shelf

* Alvotech (NASDAQ:ALVO [https://seekingalpha.com/symbol/ALVO]) filed automatic mixed securities shelf. * Filing [https://seekingalpha.com/filing/10225729] MORE ON ALVOTECH * Alvotech names veteran Linda Jónsdóttir finance chief [h... Full story

Yahoo Finance • 26 days ago

Dr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License Agreement

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years.Dr. Reddy’s Laboratories Limited (NYSE:RDY) and Alvotech announced that they have entered into a collaboration and license agreement to co... Full story

Yahoo Finance • last month

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

REYKJAVIK, ICELAND (July 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as C... Full story

Yahoo Finance • last month

Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs

REYKJAVÍK (10. JÚLÍ 2025) - Alvotech (NASDAQ: ALVO) hefur skipað Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs. Linda er reyndur alþjóðlegur stjórnandi á sviði rekstrar og fjármála. Hún hefur áður gegnt leiðtogastöðum fyrirtækja... Full story

Yahoo Finance • last month

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland

REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today annou... Full story

Yahoo Finance • last month

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland

REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the expansion o... Full story

Yahoo Finance • last month

Alvotech kaupir alla starfsemi Ivers-Lee Grou

Ivers-Lee er rótgróið fjölskyldufyrirtæki með höfuðstöðvar í Sviss og útibú í ÞýskalandiMeð kaupunum býr Alvotech sig undir mikinn vöxt eftirspurnar og eykur afköst í samsetningu og pökkun REYKJAVIK OG BURGDORF Í SVISS (9. JÚLÍ 2025) Alvo... Full story

Yahoo Finance • last month

Alvotech erweitert seine Kapazitäten in den Bereichen Montage und Verpackung mit der Akquisition von Ivers-Lee in der Schweiz

REYKJAVIK, ISLAND UND BURGDORF, SCHWEIZ (9. JULI 2025) — Alvotech (NASDAQ: ALVO), ein globales Biotech-Unternehmen, das sich auf die Entwicklung und Herstellung von Biosimilars für Patienten weltweit spezialisiert hat, gab heute die Erweit... Full story

Yahoo Finance • 2 months ago

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) --  Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco L... Full story

Yahoo Finance • 2 months ago

Advanz Pharma semur við Alvotech um markaðssetningu í Evrópu á hliðstæðu við líftæknilyfið Cimzia

REYKJAVÍK og LONDON, BRETLANDI (1. júlí 2025) - Alvotech (NASDAQ: ALVO) og Advanz Pharma tilkynntu í dag að félögin hafi gert með sér samning um markaðssetningu AVT10 í Evrópu. AVT10 er hliðstæða við líftæknilyfið Cimzia (certolizumab pego... Full story

Yahoo Finance • 2 months ago

Alvotech and Advanz Pharma ingår europeiskt leverans- och kommersialiseringsavtal för biosimilarkandidat till Cimzia® (certolizumab pegol)

REYKJAVIK, ISLAND och LONDON, UK (1 juli 2025) — Alvotech (NASDAQ: ALVO), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära läkemedel för patienter över hela världen, och Advanz Pharma... Full story

Yahoo Finance • 2 months ago

US High Growth Tech Stocks To Watch In June 2025

Over the last 7 days, the United States market has risen 1.9% and is up 12% over the last 12 months, with earnings expected to grow by 14% per annum over the next few years. In this context of robust market performance, identifying high gr... Full story

Yahoo Finance • 2 months ago

Positive Top Line Results from Confirmatory Efficacy Study  for Proposed Biosimilar to Xolair ® (omalizumab)

REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kas... Full story